Market Assessment: Market analysis for monitoring gout disease at the point of need using a CMOS-based device

在本实验室，我们研制了一种新型的便携式生物传感器，用于电化学发光检测尿酸。该产品包括基于互补金属氧化物半导体(CMOS)芯片的传感平台、读取器和一瓶反应缓冲液，以与目标样品混合进行化学发光反应。它可以用来跟踪尿酸水平和监测痛风的早期迹象。痛风的患病率和发病率在世界范围内呈上升趋势。大约5.2%的加拿大男性和2.4%的加拿大女性受到痛风的影响，这种疾病的发病率随着年龄的增长而增加。因此，对于痛风患者或痛风高危人群来说，监测他们的尿酸水平是很重要的。在这份提案的框架内，我们将进行市场分析，以确定我们的设备与市场上现有技术竞争的潜力。市场规模、用户派生的设计规范将用于与最终用户的交互。一旦市场分析完成，我们将决定下一步行动，例如进入下一阶段的中试测试和原型制作，以及创办一家公司。总体而言，如果成功，该项目将允许为痛风病患者开发新技术，从而提高生活质量，降低伤残调整寿命。

In our lab we developed a novel portable biosensor for uric acid detection via electrochemiluminescence. The product includes a sensing platform based on a Complementary metaloxide-semiconductor (CMOS) chip, a reader, and a vial of reaction buffer to mix with the target sample for chemiluminescence reaction. It can be used to track the level of uric acid and monitor for early signs of gout. The prevalence and incidence of gout are increasing worldwide. Approximately 5.2% of Canadian males and 2.4% of Canadian females are affected by gout, and the incidence of this disease increases with age. Therefore, it is important for people with gout disease or at high risk of gout disease to monitor their level of uric acid. Within the frame of this proposal, we will perform a market analysis to identify the potential of our device to compete with existing technologies available on the market. Market size, user-derived design specifications will be obtained for interactions with end users. Once the market analysis is completed, we will decide on the next steps, such as to move to the next phase of pilot testing and prototyping, and starting up a company. Overall, if successful, the project will allow for the development of novel technology for individuals suffering from gout disease, leading to an improved quality of life and lower disability adjusted life years.